Page last updated: 2024-09-04

resiquimod and Infections

resiquimod has been researched along with Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brugman, S; den Hartog, G; Meijer, B; Savelkoul, HFJ; van Neerven, RJJ; van Osch, TLJ; Vos, M	1

Other Studies

1 other study(ies) available for resiquimod and Infections

Article	Year
BAFF augments IgA2 and IL-10 production by TLR7/8 stimulated total peripheral blood B cells. European journal of immunology, 2018, Volume: 48, Issue:2 Topics: Animals; B-Cell Activating Factor; B-Lymphocytes; Blood Cells; Cells, Cultured; Humans; Hypersensitivity; Imidazoles; Immunoglobulin A; Immunoglobulin Class Switching; Infections; Interleukin-10; Lymphocyte Activation; Mice; Mucous Membrane; Oligodeoxyribonucleotides; T-Lymphocytes; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Necrosis Factor Ligand Superfamily Member 13	2018

Article

Year

BAFF augments IgA2 and IL-10 production by TLR7/8 stimulated total peripheral blood B cells.

European journal of immunology, 2018, Volume: 48, Issue:2

Topics: Animals; B-Cell Activating Factor; B-Lymphocytes; Blood Cells; Cells, Cultured; Humans; Hypersensitivity; Imidazoles; Immunoglobulin A; Immunoglobulin Class Switching; Infections; Interleukin-10; Lymphocyte Activation; Mice; Mucous Membrane; Oligodeoxyribonucleotides; T-Lymphocytes; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Necrosis Factor Ligand Superfamily Member 13

2018